The growth track for OPKO Health Inc. (OPK) has changed recently

OPKO Health Inc. (NASDAQ: OPK) stock jumped 1.36% on Friday to $1.49 against a previous-day closing price of $1.47. With 2.17 million shares changed hands, the volume of the stock remained lighter than its average volume of 2.45 million shares. During the session, the Diagnostics & Research company that operates in wider Healthcare sector, reached to the highest price of $1.5199 whereas the lowest price it dropped to was $1.4400. The 52-week range on OPK shows that it touched its highest point at $4.63 and its lowest point at $1.03 during that stretch. It currently has a 1-year price target of $4.95. Beta for the stock currently stands at 1.71.

Top 5 Undervalued Stocks To Own In 2023

Microchip Maker Releases "World's Most Powerful Data Center CPU". It could allow the company who manufactures it to lead the industry as the global microchip shortage continues into the coming year. We've put together a free research report that explains all the details. Not only will you find out why analysts believe this chip manufacturer could lead the pack, you will also discover four more potential winners for the coming year.

Click here to download your Free Research Report…


Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of OPK was up-trending over the past week, with a rise of 12.03%, but this was up by 29.57% over a month. Three-month performance dropped to -13.87% while six-month performance fell -41.34%. The stock lost -66.37% in the past year, while it has gained 19.20% so far this year. A look at the trailing 12-month EPS for OPK yields -0.45 with Next year EPS estimates of -0.23. For the next quarter, that number is -0.11. This implies an EPS growth rate of -197.40% for this year and 50.00% for next year. EPS is expected to grow by 12.00% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of 11.90%.

Float and Shares Shorts:

At present, 750.40 million OPK shares are outstanding with a float of 416.76 million shares on hand for trading. On Oct 13, 2022, short shares totaled 37.44 million, which was 4.85% higher than short shares on Sep 14, 2022. In addition to Dr. Phillip Frost Ph.D. as the firm’s Chairman & CEO, Dr. Jane H. Hsiao M.B.A., MBA, Ph.D. serves as its Vice Chairman & Chief Technical Officer.

Institutional Ownership:

Through their ownership of 25.30% of OPK’s outstanding shares, institutional investors have minority control over the company. Other institutions hold 9.28% of OPK, in contrast to 40.28% held by mutual funds. Shares owned by individuals account for 17.00%. As the largest shareholder in OPK with 5.13% of the stake, The Vanguard Group, Inc. holds 39,614,429 shares worth 39,614,429. A second-largest stockholder of OPK, BlackRock Fund Advisors, holds 29,666,569 shares, controlling over 3.84% of the firm’s shares. Dimensional Fund Advisors LP is the third largest shareholder in OPK, holding 10,823,641 shares or 1.40% stake. With a 1.65% stake in OPK, the Vanguard Total Stock Market Index is the largest stakeholder. A total of 12,728,537 shares are owned by the mutual fund manager. The Vanguard Small Cap Index Fund, which owns about 1.42% of OPK stock, is the second-largest Mutual Fund holder. It holds 10,951,164 shares valued at 13.69 million. iShares Russell 2000 ETF holds 1.18% of the stake in OPK, owning 9,095,249 shares worth 11.37 million.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for OPK since 6 analysts follow the stock currently. There are 5 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 1 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential. With OPK analysts setting a high price target of $8.50 and a low target of $3.00, the average target price over the next 12 months is $4.95. Based on these targets, OPK could surge 470.47% to reach the target high and rise by 101.34% to reach the target low. Reaching the average price target will result in a growth of 232.21% from current levels.

EPS: Estimates vs Actual

It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. OPK will report FY 2022 earnings on 02/23/2024. Analysts have provided yearly estimates in a range of -$0.35 being high and -$0.51 being low. For OPK, this leads to a yearly average estimate of -$0.44. The earnings surprise of a firm occurs when the actual results change from the consensus earnings estimate. OPKO Health Inc. surprised analysts by -$0.03 when it reported -$0.11 EPS against a consensus estimate of -$0.08. The surprise factor in the prior quarter was -$0.15. Based on analyst estimates, the high estimate for the next quarter is -$0.08 and the low estimate is -$0.16. The average estimate for the next quarter is thus -$0.11.

Summary of Insider Activity:

Insiders traded OPK stock several times over the past three months with 32 Buys and 0 Sells. In these transactions, 600,000 shares were bought while 0 shares were sold. The number of buy transactions has increased to 277 while that of sell transactions has remained unmoved to 0 over the past year. The total number of shares bought during that period was 85,510,751 while 0 shares were sold.

Leave a Comment

Your email address will not be published. Required fields are marked *